In vivo: ↓ hepatic injury, steatosis, fibrosis, oxidative stress and inflammation; inhibited TXNIP and NLRP3. In vitro: suppressed NLRP3 activation, restored lipid metabolism. This evidence concerns the gene NLRP3 and steatosis.